FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has provided an Emergency Use Authorization (EUA) for the LightMix® Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa. The test is used for the detection of Ebola Zaire Virus in whole blood samples using the large installed base of Roche's LightCycler® 480 or cobas z 480 instruments.

"The LightMix® Ebola Zaire test is an easy-to-use molecular diagnostic test providing a solution for healthcare professionals to quickly detect the virus and start patient treatment as early as possible," said Roland Diggelman COO, Roche Diagnostics Division. "As a leader in diagnostics, Roche is committed to providing testing solutions for the world's most challenging healthcare emergencies. The FDA's granting of this EUA supports our commitment to healthcare professionals working to combat this deadly disease."

The LightMix® Ebola Zaire rRT-PCR Test has also been CE marked by the test's manufacturer, TIB MOLBIOL GmbH, and is available for use on the LightCycler® 480 or cobas z 480 instruments in markets accepting the CE mark. In addition, TIB MOLBIOL GmbH has submitted an Expression of Interest (EOI) for Emergency Assessment by the World Health Organization Prequalification of the In vitro Diagnostics Programme.

Source:

Roche

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Diagnostics Limited. (2019, June 19). FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test. News-Medical. Retrieved on October 23, 2019 from https://www.news-medical.net/news/20141230/FDA-provides-Emergency-Use-Authorization-for-Roches-LightMix-Ebola-Zaire-rRT-PCR-Test.aspx.

  • MLA

    Roche Diagnostics Limited. "FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test". News-Medical. 23 October 2019. <https://www.news-medical.net/news/20141230/FDA-provides-Emergency-Use-Authorization-for-Roches-LightMix-Ebola-Zaire-rRT-PCR-Test.aspx>.

  • Chicago

    Roche Diagnostics Limited. "FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test". News-Medical. https://www.news-medical.net/news/20141230/FDA-provides-Emergency-Use-Authorization-for-Roches-LightMix-Ebola-Zaire-rRT-PCR-Test.aspx. (accessed October 23, 2019).

  • Harvard

    Roche Diagnostics Limited. 2019. FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test. News-Medical, viewed 23 October 2019, https://www.news-medical.net/news/20141230/FDA-provides-Emergency-Use-Authorization-for-Roches-LightMix-Ebola-Zaire-rRT-PCR-Test.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Roche launches new protein melting application for real-time PCR LightCycler 1536 instrument